Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:e3-
Published online before print July 22, 2002, doi: 10.1161/01.HYP.0000029107.39065.09
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/e3    most recent
01.HYP.0000029107.39065.09v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, I. B.
Right arrow Articles by Creager, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, I. B.
Right arrow Articles by Creager, M. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Other hypertension
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Hypertension. 2002;40:e3.)
© 2002 American Heart Association, Inc.


Letters to the Editor

Nitric Oxide and Regulation of Arterial Elasticity: Right Idea, Wrong Vascular Bed?

Ian B. Wilkinson

Department of Clinical Pharmacology, Addenbrooke’s Hospital, Cambridge, England, United Kingdom

David J. Webb

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland, United Kingdom

John R. Cockcroft

Wales Heart Research Institute, University Hospital, Cardiff, Wales, United Kingdom, E-mail cockcroftjr@cf.ac.uk


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

We were disappointed with the reply to our recent letter about the involvement of nitric oxide (NO) in the regulation of arterial stiffness.1 Although we enjoyed the well-written and robust reply to the points we raised, we feel obliged to point out a number of factual inaccuracies that may lead to misinterpretation of the debate and to refocus the issue on several points they seem to misunderstand.

Although Kinlay et al agree with our contention that pulse wave velocity in the brachial artery changes little with age, they suggest that this is irrelevant to their recent findings that NO regulates several indices of brachial artery elasticity (including pulse wave velocity) in vivo. However, we would disagree, because the same group have previously published data demonstrating that aging progressively impairs endothelium-dependent vasodilatation in the forearm vascular bed.2 Therefore, if, as they maintain, NO is important in regulating arterial elasticity in the arm, surely brachial artery elasticity should decrease with age. Indeed, we would be interested to know how the authors reconcile both sets of observations.

Kinlay et al also suggest that their own technique "is independent of blood flow, as it is a direct assessment of arterial distension." However, as the authors well know, shear stress is the main physiological stimulus to endothelial nitric oxide production in vivo. Therefore, any drug that reduces blood flow will reduce shear stress and, thus, nitric oxide production in the large arteries. This means that changes in blood flow could influence large artery stiffness indirectly . . . [Full Text of this Article]

Scott Kinlay; Peter Ganz; Mark A. Creager

Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, E-mail skinlay@rics.bwh.harvard.edu